Edwards Lifesciences Current Liabilities Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 123.91  2.19  1.8%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Current Liabilities of Edwards Lifesciences Corporation with missing and latest data points interpolated. The current portion of Total Liabilities, reported if the company operates a classified balance sheet that segments current and non-current liabilities.
View

476.2 M

            10 Years Trend  
Increasing
Slightly volatile
 Current Liabilities 
      Timeline 

Edwards Lifesciences Current Liabilities Over Time

2016-12-31  532,500,000 
2017-12-31  532,500,000 
2018-12-31  476,200,000 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  378,707,692
Geometric Mean  363,904,272
Coefficient Of Variation  27.92
Mean Deviation  84,823,669
Median  347,400,000
Standard Deviation  105,716,819
Range  347,900,000
R Value  0.88
R Squared  0.78
Significance  0.00007002
Slope  23,910,440

Currently Trending

VHT   
 PCX 
Purchased over 90 shares of
few hours ago ago
Traded for 162.09
VWO   
 PCX 
Purchased over 90 shares of
few hours ago ago
Traded for 48.23
MYSZ   
 NASDAQ 
Purchased over 100 shares of
few hours ago ago
Traded for 2.66